Sana Biotechnology (SANA) Research & Development (2020 - 2026)

Sana Biotechnology has reported Research & Development for 7 years, with the latest figure at $28.7 million in Q1 2026.

• Quarterly Research & Development fell 22.78% year-over-year to $28.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.5 million (down 19.36% YoY) and the FY2025 annual result came in at $132.0 million, down 38.81% from the prior year.
• Research & Development declined to $28.7 million in Q1 2026 per SANA's latest filing, from $34.9 million in the prior quarter.
• Over five years, Research & Development peaked at $76.7 million in Q3 2022 and troughed at $1.9 million in Q4 2024.
• A 5-year average of $48.9 million and a median of $56.4 million in 2024 frame the typical range for Research & Development.
• The sharpest annual moves came in 2023 and 2025: Research & Development sank 89.05% in 2023, then jumped 1738.11% in 2025.
• Over 5 years, Research & Development stood at $63.9 million in 2022, then tumbled by 89.05% to $7.0 million in 2023, then plunged by 72.86% to $1.9 million in 2024, then surged by 1738.11% to $34.9 million in 2025, then decreased by 17.77% to $28.7 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $28.7 million, $34.9 million, and $30.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.